Covered recipient · General Payments record
JULIA THOMAS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$5,882.76
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $693.14 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PROTEGA PHARMACEUTIALS INC | $167.17 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $118.65 | 1 |
| Nevro Corp. | $117.61 | 1 |
| PFIZER INC. | $100.83 | 6 |
| Averitas Pharma Inc. | $77.04 | 3 |
| Medtronic, Inc. | $57.78 | 1 |
| SCILEX PHARMACEUTICALS INC. | $54.06 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Averitas Pharma Inc. | $24.10 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133455962 | CMS |
| Averitas Pharma Inc. | $23.93 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133455967 | CMS |
| Averitas Pharma Inc. | $29.01 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133455971 | CMS |
| Boston Scientific Corporation | $118.65 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092473951 | CMS |
| Medtronic, Inc. | $57.78 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116983937 | CMS |
| Nevro Corp. | $117.61 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130738204 | CMS |
| PFIZER INC. | $13.76 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131711513 | CMS |
| PFIZER INC. | $14.57 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131575055 | CMS |
| PFIZER INC. | $13.25 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131660295 | CMS |
| PFIZER INC. | $17.50 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131880791 | CMS |
| PFIZER INC. | $20.96 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131936252 | CMS |
| PFIZER INC. | $20.79 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131211259 | CMS |
| PROTEGA PHARMACEUTIALS INC | $79.18 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147553776 | CMS |
| PROTEGA PHARMACEUTIALS INC | $87.99 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147553864 | CMS |
| SCILEX PHARMACEUTICALS INC. | $14.80 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136216491 | CMS |
| SCILEX PHARMACEUTICALS INC. | $18.10 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136286954 | CMS |
| SCILEX PHARMACEUTICALS INC. | $21.16 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136290649 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.